Reversing the Trajectory of Serious Diseases
Patients worldwide are living with serious diseases that are not adequately addressed by the current standard of care. These patients urgently need disruptive therapies that will reverse the trajectory of their diseases and restore hope for their futures.
We founded Endeavor BioMedicines to help patients with these intractable diseases.
Focusing first on fibrotic lung diseases and cancer, we are committed to advancing therapies that will potentially deliver transformational clinical benefits and revolutionize patient outcomes.